Even though we found no amyloid reduction with hIVIG, a recent in vivo study reported that natural Aβ-antibodies (Nabs-Aβ) isolated from hIVIG confer protection from Aβ toxicity along with beneficial effects on cognition in an APP transgenic mouse model of AD [24]. Here, APP is linked to Alzheimer disease.